Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. DOC
DOC logo

DOC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Healthpeak Properties Inc (DOC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
16.690
1 Day change
0.60%
52 Week Range
20.400
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Healthpeak Properties Inc (DOC) is not a strong buy for a beginner, long-term investor at this time. The technical indicators are bearish, recent financial performance is weak, and analysts have downgraded the stock. While the dividend yield is attractive, the lack of growth catalysts and negative sentiment make it prudent to hold off on investing.

Technical Analysis

The stock's MACD is negative and expanding downward, RSI is neutral at 37.56, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 16.695), but overall trends suggest bearish momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment in the options market, but the overall trading volume is relatively low.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
6

Positive Catalysts

  • Healthpeak Properties secured a $400 million unsecured delayed-draw term loan, improving liquidity and financial flexibility. The stock's dividend yield has increased to 6.9%, which may attract income-focused investors.

Neutral/Negative Catalysts

  • The company experienced a 7% decline in stock price recently, and analysts have downgraded the stock or lowered price targets. Financial performance in the latest quarter was weak, with a significant drop in net income and EPS. Technical indicators are bearish, and the stock is expected to decline further in the short term.

Financial Performance

In Q3 2025, revenue increased slightly by 0.78% YoY to $705.87 million. However, net income dropped significantly by -236.86% YoY to -$117.26 million, and EPS fell by -241.67% YoY to -$0.17. Gross margin also declined slightly to 58.65%, down -2.12% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have downgraded the stock recently. Argus downgraded it to Hold from Buy, and Wells Fargo lowered its price target to $18 from $19, citing potential occupancy losses in the near term.

Wall Street analysts forecast DOC stock price to rise
12 Analyst Rating
Wall Street analysts forecast DOC stock price to rise
6 Buy
6 Hold
0 Sell
Moderate Buy
Current: 16.550
sliders
Low
16.71
Averages
19.23
High
21
Current: 16.550
sliders
Low
16.71
Averages
19.23
High
21
Argus
Marie Ferguson
Buy
to
Hold
downgrade
AI Analysis
2026-02-05
Reason
Argus
Marie Ferguson
Price Target
AI Analysis
2026-02-05
downgrade
Buy
to
Hold
Reason
Argus analyst Marie Ferguson downgraded Healthpeak Properties to Hold from Buy.
Wells Fargo
John Kilichowski
Equal Weight
downgrade
$19 -> $18
2026-02-03
Reason
Wells Fargo
John Kilichowski
Price Target
$19 -> $18
2026-02-03
downgrade
Equal Weight
Reason
Wells Fargo analyst John Kilichowski lowered the firm's price target on Healthpeak Properties to $18 from $19 and keeps an Equal Weight rating on the shares. The firm recently toured the South SF Life Science market, which is 16msf. The company's tone was positive but Wells estimates about 500bps of occ loss in Q4 and Q1 before the second half of 2026 expected ramp.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for DOC
Unlock Now

People Also Watch